UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD-DTN): Best practice guide for hybrid closed-loop therapy.

Autor: Griffin TP; Leicester Diabetes Centre, University Hospitals of Leicester, Leicester, UK.; Diabetes Research Centre, College of Health Sciences, University of Leicester, Leicester, UK.; School of Medicine, University of Limerick, Limerick, Ireland.; Centre for Diabetes and Endocrinology, University Hospital Limerick, Limerick, Ireland., Gallen G; Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, UK., Hartnell S; Department of Diabetes and Endocrinology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Crabtree T; University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.; Translational Medical Sciences, University of Nottingham, Nottingham, UK., Holloway M; Expert by Experience, Independent Consultant, London, UK., Gibb FW; Edinburgh Centre for Endocrinology & Diabetes, Royal Infirmary of Edinburgh, Edinburgh, UK., Lumb A; Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK.; Oxford NIHR Biomedical Research Centre, Oxford, UK., Wilmot EG; University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.; Translational Medical Sciences, University of Nottingham, Nottingham, UK., Choudhary P; Leicester Diabetes Centre, University Hospitals of Leicester, Leicester, UK.; Diabetes Research Centre, College of Health Sciences, University of Leicester, Leicester, UK., Hussain S; Department of Diabetes, School of Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, UK.; Department of Diabetes and Endocrinology, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Jazyk: angličtina
Zdroj: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2023 Jul; Vol. 40 (7), pp. e15078. Date of Electronic Publication: 2023 Apr 10.
DOI: 10.1111/dme.15078
Abstrakt: This best practice guide is written with the aim of providing an overview of current hybrid closed-loop (HCL) systems in use within the United Kingdom's (UK) National Health Service (NHS) and to provide education and advice for their management on both an individual and clinical service level. The environment of diabetes technology, and particularly HCL systems, is rapidly evolving. The past decade has seen unprecedented advances in the development of HCL systems. These systems improve glycaemic outcomes and reduce the burden of treatment for people with type 1 diabetes (pwT1D). It is anticipated that access to these systems will increase in England as a result of updates in National Institute of Health and Care Excellence (NICE) guidance providing broader support for the use of real-time continuous glucose monitoring (CGM) for pwT1D. NICE is currently undertaking multiple-technology appraisal into HCL systems. Based on experience from centres involved in supporting advanced technologies as well as from the recent NHS England HCL pilot, this guide is intended to provide healthcare professionals with UK expert consensus on the best practice for initiation, optimisation and ongoing management of HCL therapy.
(© 2023 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.)
Databáze: MEDLINE
Externí odkaz: